BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11569404)

  • 1. Understanding the interaction of genetics and cellular responses in nonobese diabetic mice.
    Ridgway WM; Fathman CG
    Curr Dir Autoimmun; 2001; 4():218-38. PubMed ID: 11569404
    [No Abstract]   [Full Text] [Related]  

  • 2. Major histocompatibility complex-linked control of autoimmunity.
    Wicker LS
    J Exp Med; 1997 Oct; 186(7):973-5. PubMed ID: 9379141
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-obese diabetic transgenic mouse.
    Yamamura K; Miyazaki T; Uno M; Toyonaga T; Miyazaki J
    Springer Semin Immunopathol; 1992; 14(2):115-25. PubMed ID: 1475739
    [No Abstract]   [Full Text] [Related]  

  • 4. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic and pathogenic basis of autoimmune diabetes in NOD mice.
    Serreze DV; Leiter EH
    Curr Opin Immunol; 1994 Dec; 6(6):900-6. PubMed ID: 7710714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes.
    Slattery RM; Miller JF; Heath WR; Charlton B
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10808-10. PubMed ID: 7902572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of diabetes in the NOD mouse.
    Solomon M; Sarvetnick N
    Adv Immunol; 2004; 84():239-64. PubMed ID: 15246255
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered dendritic cells (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice.
    Boudaly S; Morin J; Berthier R; Marche P; Boitard C
    Eur Cytokine Netw; 2002; 13(1):29-37. PubMed ID: 11956018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
    Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
    J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity--towards the year 2001.
    Yeatman N; Sachs J; Bottazzo GF
    Immunol Today; 1992 Jul; 13(7):239-40. PubMed ID: 1356343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes.
    Ridgway WM; Fathman CG
    Clin Immunol Immunopathol; 1998 Jan; 86(1):3-10. PubMed ID: 9434791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
    Schmidt D; Verdaguer J; Averill N; Santamaria P
    J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure in immune regulation begets IDDM in NOD mice.
    Cameron MJ; Meagher C; Delovitch TL
    Diabetes Metab Rev; 1998 Jun; 14(2):177-85. PubMed ID: 9679670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonobese diabetic mice and the genetics of diabetes susceptibility.
    Leiter EH
    Curr Diab Rep; 2005 Apr; 5(2):141-8. PubMed ID: 15794919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor-transgenic NOD mice: a reductionist approach to understand autoimmune diabetes.
    Yang Y; Santamaria P
    J Autoimmun; 2004 Mar; 22(2):121-9. PubMed ID: 14987740
    [No Abstract]   [Full Text] [Related]  

  • 18. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-affinity major histocompatibility complex-binding peptides in type 1 diabetes.
    James EA; Kwok WW
    Diabetes; 2008 Jul; 57(7):1788-9. PubMed ID: 18586912
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic heterogeneity of autoimmune disorders in the nonobese diabetic mouse.
    Johansson AC; Lindqvist AK; Johannesson M; Holmdahl R
    Scand J Immunol; 2003 Mar; 57(3):203-13. PubMed ID: 12641648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.